Zweig-DiMenna Associates’s DexCom DXCM Stock Holding History

Zweig-DiMenna Associates’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-105,472	Closed	-$14.2M	–	115
2021 Q4	$14.2M	Sell	105,472 -8,180	-7%	-$1.18M	1.14%	30
2021 Q3	$15.5M	Buy	113,652 +8,400	+8%	+$1.06M	1.08%	33
2021 Q2	$11.2M	Buy	+105,252	New	+$10.1M	0.68%	57
2020 Q4	–	Sell	-191,736	Closed	-$19.8M	–	147
2020 Q3	$19.8M	Buy	191,736 +31,652	+20%	+$3.31M	1.34%	20
2020 Q2	$16.2M	Buy	+160,084	New	+$14.3M	1.71%	13

Other funds holding DXCM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Zweig-DiMenna Associates's DXCM Position: Q1 2022 in Review

Zweig-DiMenna Associates sold out of DexCom (DXCM) in Q1 2022, closing a stake of 105,472 shares — an estimated $14.2M sold.

Zweig-DiMenna Associates first reported a position in DXCM in Q2 2020 and held it in 5 quarters. The position peaked at $19.8M in Q3 2020. 861 funds tracked by Wall St. Rank hold DXCM as of Q1 2022.

Zweig-DiMenna Associates reported no remaining DexCom position as of Q1 2022 after selling out during the quarter.
Zweig-DiMenna Associates sold 105,472 DexCom shares in Q1 2022, an estimated $14.2M.
Zweig-DiMenna Associates first reported a position in DexCom in Q2 2020 and held it in 5 quarters.
Zweig-DiMenna Associates's DexCom position peaked at $19.8M in Q3 2020.
861 funds tracked by Wall St. Rank held DexCom as of Q1 2022.

Based on Zweig-DiMenna Associates's 13F filing for Q1 2022, filed 25 Apr 2022.